Meet Biljana Naumovic, President of U.S. Oncology, Solid Tumor at Johnson & Johnson...

On today’s episode, meet Biljana Naumovic. Biljana is the President of U.S. Oncology, Solid Tumor at  Johnson & Johnson, where she is spearheading innovative cancer  treatments and advocating for equity in healthcare.  She is committed to advancing the  organization’s solid tumor portfolio and pipeline, spanning prostate,  bladder, and lung cancer, as well as multiple novel treatment pathways.  Biljana is passionately focused on bringing medical innovation  and ultimately transforming patient care. Biljana is a physician by training  and graduated in 2001 from the Belgrade University Medical School. She  worked as a practicing physician for several years before transitioning  to industry. She also holds an executive education degree  from the London Business School.Send us Fan Mailresearchevangelist.com